➡️Next #EURONMD webinar w/ @ERN_RND & @EANeurology.
📚"Pathomechanisms of Charcot-Marie-Tooth Disease" delivered by Dr. Stefano Carlo Previtali (IRCCS Ospedale San Raffaele, Italy)
📅Oct 4th, 2023 at 16:00 CEST
ℹ️More information and registration here 👉https://t.co/ri4h9BO7KJ
Job listing for neurobiologists, stem cell biologists and mouse biologists as advertised on @WhovaSupport app at the recently concluded #ANS2022. Plenty of interesting opportunities from around Oz and one from Pittsburg uni (USA). Please RT!!
Prof. Marina Kennerson of @KennersonLab presenting recent advances on long read sequencing and genetic analysis of CMT families using @oxfordnanopore at Nanopore workshop at #ANS2022
@KennersonLab's recent work is out in Brain. A study by our post-doc Dr Anthony Cutrupi in collaboration with A/P Mario Saporta of @umiamimedicine
Novel gene-intergenic fusion involving ubiquitin E3 ligase UBE3C causes distal hereditary motor neuropathy https://t.co/KVsBEAZEoB
You have questions?
We have answers!
**SPOTS ARE LIMITED FOR IN-PERSON ATTENDANCE - REGISTER TODAY TO ENSURE YOUR SEAT**
Register for the 2022 Global CMT Research Convention: https://t.co/hAtA4XYRGS
#CMTRF#CMTresearch#globalCMTresearchconvention
When is it time for your #biotech to look at CMT as an indication? When you are looking for a rare disease with high unmet medical need, but would also benefit from a potential market of 3M ppl globally, mature natural history studies, and an existing clinical trial network.
At the @KennersonLab we have shown calpain-1 is a new gene responsible for adult onset #spinalmuscularatrophy (#SMA type 4). Our work published in #FrontiersIn Genetics expands the number of neurodegenerative diseases caused by mutations in calpain genes.
https://t.co/fklUKmwyCj
Thanks to @GeneticsAus for giving me the opportunity to present my #PhD research at #GSAA21. A fantastic conference full of engaging talks and an especially unique poster session. @KennersonLab@anzacinstitute
Read about why our CEO Susan Ruediger co-founded the @CMTRF, the progress we have made in three short years, and why the future is bright for CMT treatments and cures.
https://t.co/Q7XJcxaObj
What an incredible first day of the 2021 #GlobalCMTResearchConvention. Thank you to the more than 100 participants from over 15 countries around the world who participated!
https://t.co/vNPLt2kCB9
Excellent talks from a wide variety of perspectives to tackle CMT disease. Thank you for the presenters and organizers, learned a lot! Now, last session about Clinical trial readiness! #globalcmtresearchconvention